Brighthouse Financial Inc... (BHFAO)
NASDAQ: BHFAO
· Real-Time Price · USD
19.53
0.25 (1.30%)
At close: May 12, 2025, 1:10 PM
Brighthouse Financial Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Accident and Health Insurance Product Line Revenue | 21M | 7M | 10M | 10M | 13M | 36M | 1M | 227M |
| Accident and Health Insurance Product Line Revenue Growth | +200.00% | -30.00% | 0.00% | -23.08% | -63.89% | +3500.00% | -99.56% | n/a |
| Investment Product Revenue | 2.43B | 2.32B | 2.85B | 3.25B | 3.01B | 1.71B | 1.83B | 1.82B |
| Investment Product Revenue Growth | +4.61% | -18.77% | -12.21% | +8.04% | +76.13% | -6.46% | +0.27% | n/a |
| Life Insurance Product Line Revenue | 1.02B | 1.28B | 1.41B | 1.53B | 1.62B | n/a | n/a | n/a |
| Life Insurance Product Line Revenue Growth | -20.47% | -9.48% | -7.40% | -5.68% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 172M | 176M | 171M | 174M | 207M | 171M | 185M | 167M | 196M | 162M | 148M | 141M | 184M | 163M | 166M | 152M | 178M | 141M | 171M | 137M | 197M | 149M | 145M | 128M | -48M | 215M | 205M | 162M | 205M | 162M | 122M | n/a | 8M | 113M | 140M | n/a | 8M | n/a | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | -2.27% | +2.92% | -1.72% | -15.94% | +21.05% | -7.57% | +10.78% | -14.80% | +20.99% | +9.46% | +4.96% | -23.37% | +12.88% | -1.81% | +9.21% | -14.61% | +26.24% | -17.54% | +24.82% | -30.46% | +32.21% | +2.76% | +13.28% | -366.67% | -122.33% | +4.88% | +26.54% | -20.98% | +26.54% | +32.79% | n/a | -100.00% | -92.92% | -19.29% | n/a | -100.00% | n/a | n/a | n/a | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |